Zotefoams plc (LSE: ZTF), the London-headquartered world leader in high-performance foam technology, has disclosed that Non-Executive Director Jack Clarke purchased 4,290 ordinary shares on 9 November 2026 at a price of £4.6363 per share. The transaction, conducted on the London Stock Exchange, was notified to the company and disclosed in accordance with Article 19 of the UK Market Abuse Regulation. Director share purchases are closely watched by investors as a potential signal of insider confidence in a company's prospects and valuation.

Key Points

  • Zotefoams plc (ZTF) — LSE-listed manufacturer of high-performance foam products
  • Non-Executive Director Jack Clarke purchased 4,290 ordinary shares of 5 pence each at £4.6363 per share on 9 November 2026
  • Following the transaction, Clarke holds a beneficial interest of approximately 0.01% of Zotefoams' issued share capital
  • Investors may be watching whether further director or PDMR dealings follow this initial notification

Jack Clarke's Open-Market Share Purchase on 9 November 2026

The announcement states that Jack Clarke, serving as a Non-Executive Director of Zotefoams plc, made a single open-market purchase of 4,290 ordinary shares of 5 pence each on 9 November 2026, transacted on the London Stock Exchange (XLON). The purchase price was £4.6363 per share. This was filed as an initial notification rather than an amendment, confirming it represents a new transaction rather than a revision of a previously reported dealing. The disclosure was made in accordance with the requirements of Article 19 of the UK Market Abuse Regulation, which obliges persons discharging managerial responsibilities to report such transactions promptly.

Clarke's Post-Transaction Beneficial Interest in Zotefoams

Following the completion of this transaction, the announcement confirms that Jack Clarke is beneficially interested in 4,290 ordinary shares in the company, representing approximately 0.01% of Zotefoams' issued share capital. The announcement does not indicate any prior shareholding, suggesting this purchase establishes Clarke's initial beneficial position in the company. The total consideration paid by Clarke was not separately stated as a rounded aggregate figure in the announcement, though the per-share price and volume are individually disclosed. The company did not disclose any further commentary from Clarke or the board regarding the rationale for this purchase.

Zotefoams' Global Foam Manufacturing Operations and Product Range

Zotefoams describes itself as a world leader in high-performance foam technology, utilising environmentally friendly nitrogen expansion processes to manufacture its AZOTE® polyolefin and ZOTEK® high-performance foams, as well as T-FIT® advanced insulation products for demanding industrial markets. The group operates foam manufacturing sites across Croydon UK, Kentucky and Pennsylvania in the USA, Poland, Spain, and Vietnam, and also manufactures T-FIT® insulation in Jiangsu Province, China. This international manufacturing footprint exposes the group to currency, regulatory, and supply chain risks across multiple jurisdictions, factors that investors may consider when assessing the broader context of director share activity.